TAF9 antibody (AA 1-264)

Catalog No. ABIN7172703

Product Details anti-TAF9 Antibody

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Binding Specificity: AA 1-264

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This TAF9 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Cross-Reactivity: Human

Purification: Antigen Affinity Purified

Immunogen: Recombinant Human Transcription initiation factor TFIID subunit 9 protein (1-264AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for TAF9

Target: TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))

Alternative Name: TAF9 (TAF9 Products)

Synonyms: AK6 antibody, CGI-137 antibody, CINAP antibody, CIP antibody, MGC:1603 antibody, MGC:3647 antibody, MGC:5067 antibody, TAF2G antibody, TAFII31 antibody, TAFII32 antibody, TAFIID32 antibody, hCINAP antibody, 2310012M09Rik antibody, 2810046E22Rik antibody, 4921516M08Rik antibody, AA673500 antibody, AU045423 antibody, Ak6 antibody, Taf2g antibody, im:7089279 antibody, wu:fb16h03 antibody, zgc:153410 antibody, TATA-box binding protein associated factor 9 antibody, adenylate kinase 6 L homeolog antibody, adenylate kinase isoenzyme 6-like antibody, SAGA complex/ transcription initiation factor Taf9 antibody, TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor antibody, TAF9 antibody, Taf9 antibody, ak6.L antibody, LOC100355082 antibody, taf9 antibody

Background:

Background: Component of TFIID, the TATA-binding protein-free TAF complex (TFTC), the PCAF complex and the STAGA transcription coactivator-HAT complex. The PCAF complex consists at least of TADA2L/ADA2, SUPT3H/SPT3, TADA3L/ADA3, TAF5L/PAF65-beta, TAF6L/PAF65-alpha, TAF10/TAFII30, TAF12/TAFII20, TAF9/TAFII31 and TRRAP. The STAGA transcription coactivator-HAT complex consists at least of SUPT3H, GCN5L2, SUPT7L, TAF5L, TAF6L, TADA3L, TAD1L, TAF10, TAF12, TRRAP and TAF9. Binds N-terminal domain of p53/TP53 which is essential for transcription. Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Binds TFIIB and the Herpes simplex virus activator VP16. Forms a heterodimer with TAF6/TAFII80 in a complex with the TAF4B/TAFII105-TAF12/TAFII20 heterodimer. Also interacts with TAF5. Binds directly DNA. Increased DNA binding when complexed with TAF6/TAFII80.

Aliases: TAF9 antibody, TAF2G antibody, TAFII31 antibody, Transcription initiation factor TFIID subunit 9 antibody, RNA polymerase II TBP-associated factor subunit G antibody, STAF31/32 antibody, Transcription initiation factor TFIID 31 kDa subunit antibody, TAFII-31 antibody, TAFII31 antibody, Transcription initiation factor TFIID 32 kDa subunit antibody, TAFII-32 antibody, TAFII32 antibody

UniProt: Q16594

Pathways: Negative Regulation of intrinsic apoptotic Signaling